for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

McKesson Corporation

MCK.N

Latest Trade

203.37USD

Change

-4.38(-2.11%)

Volume

47,314

Today's Range

202.64

 - 

205.87

52 Week Range

141.33

 - 

210.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
207.75
Open
205.87
Volume
47,314
3M AVG Volume
23.04
Today's High
205.87
Today's Low
202.64
52 Week High
210.00
52 Week Low
141.33
Shares Out (MIL)
155.00
Market Cap (MIL)
32,133.64
Forward P/E
10.25
Dividend (Yield %)
0.90

Next Event

Q2 2022 Mckesson Corp Earnings Release

Latest Developments

More

Ontada Signs Strategic Agreement With Merck To Facilitate Development Of Data-Driven Insights To Impact Quality Of Cancer Care

Mckesson Says In June, U.S. DOJ Served Civil Investigative Demand On Co Seeking Documents Related To Distribution Arrangements For Ophthalmology Products

McKesson Reports Fiscal 2022 First-Quarter Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About McKesson Corporation

McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.

Industry

Biotechnology & Drugs

Contact Info

6555 State Highway 161

IRVING, TX

75039-2402

United States

+1.972.4464800

http://www.mckesson.com

Executive Leadership

Edward A. Mueller

Independent Chairman of the Board

Brian Scott Tyler

Chief Executive Officer, Director

Britt J. Vitalone

Chief Financial Officer, Executive Vice President

Tracy Faber

Chief Human Resource Officer, Executive Vice President

Nancy Flores

Executive Vice President, Chief Technology Officer, Chief Information Officer

Key Stats

1.93 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

214.3K

2020

231.1K

2021

238.2K

2022(E)

252.7K
EPS (USD)

2019

13.570

2020

14.950

2021

17.210

2022(E)

20.273
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.13
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-23.87
Return on Equity (TTM)
-7.13

Latest News

Latest News

BRIEF-Drug Distributors Announce Proposed Opioid Settlement Will Proceed To Next Phase

* DISTRIBUTORS ANNOUNCE PROPOSED OPIOID SETTLEMENT WILL PROCEED TO NEXT PHASE

U.S. state officials urge support for landmark $26 billion opioid settlement

A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments.

Germany's Phoenix buys European businesses from McKesson

German drug distributor Phoenix Group has agreed to buy parts of U.S.-based McKesson's European operations, the two companies said on Wednesday, without providing financial details.

West Virginia city takes big three drug distributors to court over opioids

The three largest U.S. drug distributors are facing trial on Monday in West Virginia in a lawsuit accusing them of fueling the opioid crisis that has resulted in 500,000 overdose deaths in the United States over two decades.

Drug distributors lose bid to escape West Virginia opioid lawsuit

The nation's "Big Three" leading drug distributors have failed to escape a lawsuit by the city of Huntington, West Virginia, and its county seeking to hold them liable for harms caused by the opioid epidemic.

McKesson loses bid to claw back funds owed to subsidiary by Orexigen

Drug distributor McKesson Corp has lost a bid in a federal appeals court to wipe out its $6.9 million debt to bankrupt obesity drug maker Orexigen Therapeutics by offsetting it against $9.1 million Orexigen owed a McKesson subsidiary.

McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine

U.S. drug distributor McKesson Corp said on Monday it had begun distribution of Johnson & Johnson's COVID-19 vaccine.

McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine

Drug distributor McKesson Corp said on Monday it had begun distribution of Johnson & Johnson's COVID-19 vaccine. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

Drug distributor McKesson raises 2021 profit forecast on COVID-19 vaccine demand

McKesson Corp said on Tuesday it has distributed over 25 million doses of Moderna's COVID-19 vaccine in January and expects its contract with U.S. government to distribute vaccines to boost its full-year earnings.

BRIEF-Mckesson Says Has Distributed Over 25 Mln Doses Of Moderna's Covid-19 Vaccine Through Jan: Conf Call

* MCKESSON SAYS HAS DISTRIBUTED OVER 25 MILLION DOSES OF MODERNA'S COVID-19 VACCINE THROUGH JAN: CONF CALL

Congresswoman urges Biden team to involve more distributors in COVID vaccine shipments

A Democratic U.S. lawmaker urged the Biden administration to involve additional major healthcare distributors in the shipment of COVID-19 vaccines to speed vaccinations, according to a letter seen by Reuters.

McKesson to replace some Moderna COVID-19 vaccines due to low temperature

McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said on Wednesday.

McKesson to replace some Moderna COVID-19 vaccines due to low temperature

McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said in a statement on Wednesday. (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)

Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaign

U.S. distribution of Moderna Inc's COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.

Moderna, McKesson and U.S. Army general ready to roll out new COVID-19 vaccine

U.S. distribution of a second COVID-19 vaccine, from Moderna, is ready to start shipping to more than 3,800 sites this weekend, vastly widening the rollout begun last week with Pfizer, the drug company and distributor McKesson said.

Cardinal Health, AmerisourceBergen book billions in opioid settlement-related charges

Drug distributors AmerisourceBergen Corp and Cardinal Health Inc on Thursday reported $7.62 billion in new charges between them related to talks to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid epidemic.

McKesson says states seek $21 billion from drug distributors in opioid settlement

McKesson Corp <MCK.N> on Tuesday said it and two other major U.S. drug distributors could be expected to pay up to $21 billion under a new proposal to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid crisis.

McKesson wins dismissal of whistleblower suit over opioid diversion

Drug distributor McKesson Corp has won dismissal of a whistleblower lawsuit by two former employees accusing the company of doing an inadequate job of protecting its product, addictive opioids, from theft.

Trump Administration picks McKesson for coronavirus vaccine distribution

The U.S. Department of Health and Human Services (HHS) said on Friday that McKesson Corp <MCK.N> would be the central distributor for future coronavirus vaccines, sending the U.S. drug distributor's shares up more than 3%.

BRIEF-Trump Administration Collaborates With McKesson For COVID-19 Vaccine Distribution

* HHS - TRUMP ADMINISTRATION COLLABORATES WITH MCKESSON FOR COVID-19 VACCINE DISTRIBUTION

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up